TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $575,000 | +250.6% | 7,638 | +24.8% | 0.01% | +400.0% |
| Q1 2022 | $164,000 | -68.2% | 6,120 | -55.8% | 0.00% | -75.0% |
| Q4 2021 | $516,000 | +230.8% | 13,850 | +489.4% | 0.00% | +300.0% |
| Q3 2021 | $156,000 | -2.5% | 2,350 | +14.6% | 0.00% | 0.0% |
| Q2 2021 | $160,000 | +25.0% | 2,050 | +51.9% | 0.00% | 0.0% |
| Q1 2021 | $128,000 | -22.0% | 1,350 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $164,000 | +134.3% | 1,350 | +68.8% | 0.00% | 0.0% |
| Q3 2020 | $70,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |